首页> 外文期刊>Gynecologic Oncology: An International Journal >Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results.
【24h】

Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results.

机译:术中近红外荧光成像用于外阴癌前哨淋巴结检测:首例临床结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Disadvantages of the combined sentinel lymph node (SLN) procedure with radiocolloid and blue dye in vulvar cancer are the preoperative injections of radioactive tracer in the vulva, posing a painful burden on the patient. Intraoperative transcutaneous imaging of a peritumorally injected fluorescent tracer may lead to a one-step procedure, while maintaining high sensitivity. Aim of this pilot study was to investigate the applicability of intraoperative fluorescence imaging for SLN detection and transcutaneous lymphatic mapping in vulvar cancer. METHODS: Ten patients with early stage squamous cell carcinoma of the vulva underwent the standard SLN procedure. Additionally, a mixture of 1 mL patent blue and 1 mL indocyanin green (ICG; 0.5 mg/mL) was injected immediately prior to surgery, with the patient under anesthesia. Color and fluorescence images and videos of lymph flow were acquired using a custom-made intraoperative fluorescence camera system. The distance between skin and femoral artery was determined on preoperative CT-scan as a measure for subcutaneous adipose tissue. RESULTS: In 10 patients, SLNs were detected in 16 groins (4 unilateral; 6 midline tumors). Transcutaneous lymphatic mapping was possible in five patients (5 of 16 groins), and was limited to lean patients, with a maximal distance between femoral artery and skin of 24 mm, as determined on CT. In total, 29 SLNs were detected by radiocolloid, of which 26 were also detected by fluorescence and 21 were blue. CONCLUSIONS: These first clinical results indicate that intraoperative transcutaneous lymphatic mapping using fluorescence is technically feasible in a subgroup of lean vulvar cancer patients.
机译:目的:外阴癌中放射性胶体和蓝色染料联合前哨淋巴结(SLN)手术的缺点是术前在外阴注射放射性示踪剂,给患者带来了痛苦的负担。术中经皮穿刺注射荧光示踪剂的成像可能导致一步操作,同时保持高灵敏度。这项初步研究的目的是调查术中荧光成像在外阴癌中SLN检测和经皮淋巴测绘的适用性。方法:10例早期外阴鳞状细胞癌患者接受了标准的SLN手术。此外,在手术即将进行之前,将1 mL漆蓝和1 mL吲哚青绿(ICG; 0.5 mg / mL)的混合物注射至麻醉状态。使用定制的术中荧光摄像系统获取彩色和荧光图像以及淋巴液的视频。术前CT扫描确定皮肤和股动脉之间的距离,作为皮下脂肪组织的量度。结果:在10例患者中,在16个腹股沟(4个单侧; 6个中线肿瘤)中检测到SLN。经皮淋巴标测可能在五名患者中进行(16个腹股沟中的5个),并且仅限于瘦型患者,根据CT的测定,股动脉和皮肤之间的最大距离为24 mm。总共通过放射性胶体检测到29个SLN,其中还通过荧光检测到26个,蓝色为21个。结论:这些最初的临床结果表明,在瘦肉型外阴癌患者的亚组中,使用荧光术中经皮经皮淋巴作图在技术上是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号